In the BioHarmony Drug Report Database
Benemid (probenecid) is a small molecule pharmaceutical. Probenecid was first approved as Benemid on 1982-01-01. It is used to treat gonorrhea, gout, and neurosyphilis in the USA. The pharmaceutical is active against solute carrier family 22 member 6. In addition, it is known to target solute carrier organic anion transporter family member 1C1 and transient receptor potential cation channel subfamily V member 2.
Image (chem structure or protein)